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Abstract
Background: Alagille syndrome is a developmental disorder caused predominantly by mutations in the Jagged1 (JAG1)
gene, which encodes a ligand for Notch family receptors. A characteristic feature of Alagille syndrome is intrahepatic bile
duct paucity. We described previously that mice doubly heterozygous for Jag1 and Notch2 mutations are an excellent
model for Alagille syndrome. However, our previous study did not establish whether bile duct paucity in Jag1/Notch2
double heterozygous mice resulted from impaired differentiation of bile duct precursor cells, or from defects in bile duct
morphogenesis.
Methodology/Principal Findings: Here we characterize embryonic biliary tract formation in our previously described Jag1/
Notch2 double heterozygous Alagille syndrome model, and describe another mouse model of bile duct paucity resulting
from liver-specific deletion of the Notch2 gene.
Conclusions/Significance: Our data support a model in which bile duct paucity in Notch pathway loss of function mutant
mice results from defects in bile duct morphogenesis rather than cell fate specification.
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Introduction
The primary functional cells of the mammalian liver are the
hepatocytes and the epithelial bile duct cells, or cholangiocytes (for
recent reviews, see references [1–3]). During liver development,
both hepatocytes and cholangiocytes differentiate from bipotential
progenitor cells termed hepatoblasts [4,5]. Hepatoblasts located in
the liver parenchyma differentiate into hepatocytes, while
hepatoblasts located at the interface of the portal mesenchyme
(which surrounds the portal vein) and the liver parenchyma
differentiate into the biliary epithelial cells. Initially, biliary
epithelial cells form a continuous single cell layer termed the
ductal plate (reviewed in [5]). The ductal plate subsequently
undergoes morphogenesis and remodeling to generate the
epithelial bile ducts. Defects in bile duct formation can lead to
an impairment of bile duct flow (cholestasis), and result in a diverse
group of both genetic and acquired biliary tract disorders termed
cholangiopathies (reviewed in [6,7]).
The Notch signaling pathway is an evolutionarily conserved
intercellular signaling mechanism (reviewed in [8,9]), and
mutations in its components disrupt embryonic development in
diverse organisms and cause inherited disease syndromes in
humans. Mutations in the JAG1 gene, which encodes a ligand for
Notch family receptors, cause Alagille syndrome [10,11]. Alagille
syndrome (OMIM #118450) is a pleiotropic developmental
disorder characterized by cholestasis and jaundice caused by
intrahepatic bile duct paucity, congenital heart defects, vertebral
defects, eye abnormalities, facial dysmorphism, and kidney
abnormalities [12–14]. Alagille syndrome exhibits autosomal
dominant inheritance, and analysis of the types of JAG1 mutations
in Alagille syndrome patients suggest JAG1 haploinsufficiency as
the primary cause of Alagille syndrome.
We have described previously a mouse model for Alagille
syndrome [15]. Mice heterozygous for a Jag1 null allele, which
have the same genotype as Alagille syndrome patients, exhibited
haploinsufficient eye defects but did not exhibit other phenotypic
abnormalities characteristic for Alagille syndrome [16]. However,
mice doubly heterozygous for a Jag1 null allele and a Notch2
hypomorphic allele exhibited most of the clinically relevant
features of Alagille syndrome, including bile duct paucity [15].
Our previous studies of these mice concentrated on analysis of late
embryonic and postnatal livers, and did not establish whether bile
duct paucity in Jag1/Notch2 double heterozygous mice was due to
defects in differentiation of bile duct precursors from the
bipotential hepatoblast, or defects in morphogenesis of the ductal
plate.
A recent study of Hairy and enhancer of split 1 (Hes1)-null mice
suggested that the role of Notch signaling during biliary
development was in the control of biliary tract morphogenesis,
rather than in a hepatocyte-cholangiocyte cell fate specification
PLoS ONE | www.plosone.org 1 March 2008 | Volume 3 | Issue 3 | e1851decision [17]. However, other genes encoding Hes-related bHLH
proteins are also Notch targets, raising the possibility that Hes1-
null mice may not reflect the full extent of the role played by the
Notch signaling pathway during biliary development. In addition,
since Hes1-null mice die perinatally from defects unrelated to the
liver defects [18], morphogenesis and maturation of the intrahe-
patic biliary system cannot be followed during the early postnatal
period when major biliary tract remodeling and maturation events
take place [5].
In this paper, we characterize embryonic biliary tract formation
in the previously described Jag1/Notch2 double heterozygote
mouse model of Alagille syndrome. We also describe another
mouse model of bile duct paucity resulting from liver-specific
deletion of the Notch2 gene. Our data demonstrate a requirement
for Jag1/Notch2-mediated signaling in bile duct formation in mice,
and support a model in which bile duct paucity in Notch pathway
loss of function mutant mice results from defects in bile duct
morphogenesis rather than cell fate specification.
Results





Our previous study [15] analyzed late embryonic and postnatal
livers, and did not establish whether bile duct paucity in mice
doubly heterozygous for a Jag1 null allele (Jag1
dDSL) [16] and a
Notch2 hypomorphic allele (Notch2
del1) [19] was due to defects in
differentiation of bile duct precursors from the bipotential
hepatoblast, or whether it was due to defects in morphogenesis
of the ductal plate. Therefore, we analyzed livers of Jag1
dDSL/+
Notch2
del1/+ double heterozygous mice by cytokeratin immuno-
staining from embryonic day (E) 16.5 through postnatal day (P) 7.
At E16.5 in control littermate embryos, cytokeratin immunostain-
ing revealed the presence of a partly bilayered ductal plate at the
interface of the portal mesenchyme and the liver parenchyma
(Fig. 1A). Over the next several days, the ductal plate remodels by
a process in which focal dilations appear between the two cell
layers of the plate (Fig. 1C,E). By P7, some of these focal dilations
give rise to patent epithelial bile ducts incorporated into the portal
mesenchyme (Fig. 1G), while the remainder of the ductal plate
involutes. Cytokeratin immunostaining of liver sections from
Jag1
dDSL/+ Notch2
del1/+ double heterozygous mice revealed that
they were very similar to control littermate sections through at
least P0. In the Jag1
dDSL/+ Notch2
del1/+ mice, a ductal plate formed
(Fig. 1B) and focal dilations appeared (Fig. 1D,F). However,
postnatal remodeling to form a patent epithelial bile duct did not
occur. Instead, as we reported in our initial study [15], by P7 only
ductal plate remnants remained in most portal tracts (Fig. 1H).
These results indicate that in the Jag1/Notch2 double heterozygote
mouse, bile duct paucity results from defects in bile duct
morphogenesis, not from defects in differentiation of bile duct
precursors from the bipotential hepatoblast.
Liver-specific Notch2 deletion results in defects in bile
duct morphogenesis, but not ductal plate formation
Our previous study was the first to implicate a critical role for
the Notch2 gene in bile duct formation [15]. The Notch2 protein is
expressed in periportal hepatoblasts near or adjacent to Jag1-
expressing cells surrounding the portal veins in mice [15,17,20].
Further support for a critical role for the Notch2 gene in bile duct
formation and/or maintenance comes from recent studies on
Alagille syndrome patients. While improved mutation detection
protocols can now identify JAG1 mutations in approximately 94%
of patients diagnosed with Alagille syndrome [21], there are still
some Alagille syndrome patients in whom no JAG1 mutations can
be identified. Recently, heterozygous NOTCH2 mutations were
identified in a subset of Alagille syndrome patients who lack JAG1
mutations [22].
To specifically assess the role of the Notch2 gene in bile duct
formation in mice, we disrupted Notch2 function in the liver
utilizing mice expressing Cre recombinase under the control of the
Albumin 1 promoter (Alb1-Cre) [23,24]. We crossed Notch2
flox/
Notch2
flox mice with mice doubly heterozygous for the Alb1-Cre
transgene and either the Notch2
del2 or Notch2
del3 alleles. Both of
these Notch2 mutant alleles behave genetically as null alleles [25].





flox were analyzed. Since no differenc-
Figure 1. Defects in embryonic bile duct morphogenesis in
Jag1
dDSL/+ Notch2
del1/+ mice. Cytokeratin immunostaining of control
littermate and Jag1
dDSL/+ Notch2
del1/+ liver sections at the indicated
ages. A,B. At E16.5, both control (A) and Jag1
dDSL/+ Notch2
del1/+ (B)
have formed a partly bilayered ductal plate (arrowheads). C–F. Over the
next several days, focal dilations (arrowheads) form in the ductal plate
of both control and mutant embryos. Other regions of the ductal plate
begin to regress. G,H. At P7, the focal dilations have formed epithelial
bile ducts incorporated into the portal mesenchyme (arrows) in the
control liver (G), while the Jag1
dDSL/+ Notch2
del1/+ liver (H) exhibits only
ductal plate remnants (arrowheads).
doi:10.1371/journal.pone.0001851.g001
Bile Duct Morphogenesis
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del2/
Notch2
flox and Alb1-Cre/+; Notch2
del3/Notch2
flox mice, mice of both
genotypes were designated Notch2-cko (for Notch2 conditional
knockout) in this report. Excision of the Notch2
flox allele was
observed in liver DNA of Notch2-cko mice, but not in kidney DNA
of these mice (Fig. 2).
Notch2-cko mice were smaller than their littermates (Fig. 3A), and
at P8-P9 were approximately 19% lighter than their littermates
(4.360.1 grams Notch2-cko versus 5.360.1 grams control litter-
mates). This weight difference was maintained through at least 4–5
weeks of age, when Notch2-cko mice were approximately 15%
lighter than their littermates. Gross examination of the livers of the
Notch2-cko mice revealed that Notch2-cko livers exhibited focal areas
of necrosis (Fig. 3C). These necrotic areas may arise from
disruption of bile acid flow, since bile acids are strong detergents
and buildup in the liver can lead to necrosis, fibrosis and cirrhosis
[6].
The biliary tract defects exhibited by Notch2-cko mice were very
similar to those exhibited by Jag1
dDSL/+ Notch2
del1/+ mice
(compare Fig. 1 with Fig. 4). Examination of histological sections
of the livers of Notch2-cko mice revealed that few morphologically
identifiable bile ducts were present (Fig. 4B). Analysis of Dolichos
biflorus agglutinin (DBA) lectin expression, a cholangiocyte marker
[26], revealed that DBA-positive cells formed patent bile ducts
adjacent to the portal veins in littermate control mice (Fig. 4C,E).
In Notch2-cko mice, DBA-positive cells were present in small
numbers adjacent to the portal veins, but these cells were not
arranged into patent epithelial ducts (Fig. 4D,F). Biliary tract
defects were similar using either the Notch2
del2 (Fig. 4B,D) or
Notch2
del3 (Fig. 4F) allele in combination with the Notch2
flox allele.
Similarly to portal tracts of Jag1
dDSL/+ Notch2
del1/+ mice,
cytokeratin immunostaining revealed that by P7 only ductal plate
remnants were detected in most Notch2-cko portal tracts (Fig. 4H),
while well-formed bile ducts incorporated into the portal
mesenchyme were present in the littermate controls (Fig. 4G).
At 4–5 weeks of age, clinical chemistry analysis of serum
revealed that, as a group, Notch2-cko mice had elevated levels of
alkaline phosphatase, alanine aminotransferase, and total bilirubin
(Table 1). Elevated levels of these parameters are indicative of liver
and biliary dysfunction. However, some Notch2-cko mice had
alkaline phosphatase, alanine aminotransferase, and total bilirubin
levels within the normal range. We also tested blood urea nitrogen
levels, which when elevated is indicative of kidney dysfunction. As
expected, blood urea nitrogen levels in Notch2-cko mice were not




Notch signaling regulates bile duct morphogenesis
independently of HNF6 and HNF1b expression
Previous studies have shown that biliary tract morphogenesis is
dependent on the transcription factors Hepatocyte Nuclear
Factor-6 (Hnf6; Onecut1 – Mouse Genome Informatics) and
HNF1b (Tcf2 – Mouse Genome Informatics). Mice homozygous
for a targeted null mutation of the Hnf6 gene [27], or with liver-
specific deletion of the Hnf1b gene [28], fail to properly remodel
the ductal plate to form patent bile ducts and exhibit persistence of
ductal plate remnants. HNF1b expression was strongly downreg-
ulated in livers of Hnf6-null mice, indicating that the Hnf6 gene
functioned upstream of the Hnf1b gene [27].
We tested by immunohistochemistry whether the HNF6 and
HNF1b proteins were expressed in the periportal region of
Jag1
dDSL/+ Notch2
del1/+ and Notch2-cko mice. HNF1b protein
expression was observed in the periportal region of Notch2-cko mice
at P0 and P7 (Fig. 5B,D). Similarly, HNF6 protein expression was
observed in the periportal region of Jag1
dDSL/+ Notch2
del1/+ mice
at P0 (Fig. 5F). These data suggest that the etiology of the bile duct
morphogenesis defects in the Notch pathway mutants is
independent of the function of the HNF6 and HNF1b proteins.
Independent functioning of the Notch pathway and the HNF6/
HNF1b pathway is supported by the finding that Jag1 and Hes1
expression is unaffected in fetal livers of Hnf6-null mice [27].
Discussion
The Notch signaling pathway is frequently utilized to specify cell
fate during bipotential cell fate decisions [8,9], so an attractive
Figure 2. Conditional excision of the Notch2
flox allele by the
Alb1-Cre transgene. Southern blot of SacI/EcoRI- digested DNA
isolated at P4. Excision of the Notch2
flox allele (asterisk indicates the
excised allele) was observed only in liver DNA of Notch2-cko mice (lane
2), but not in kidney DNA of Notch2-cko mice (lanes 5,6). Genotype of




Figure 3. Jaundice and bile duct paucity in Notch2-cko mice. A.
Notch2-cko mouse (bottom) and control littermate (top) at P3. The
Notch2-cko mouse exhibits jaundice and growth retardation. B,C. Livers
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dDSL/+
Notch2
del1/+ mice was reduced differentiation of cholangiocytes
from the bipotential hepatoblast. The first indication that this
model was likely incorrect came from analysis of mice homozygous
for a null mutation of the Hes1 gene, which encodes a basic helix-
loop-helix protein that is a downstream effector of the Notch
pathway. The Hes1-null mice formed a relatively-normal ductal
plate consisting of cytokeratin- and DBA-positive cholangiocyte
precursors, suggesting that the primary defect in these mice was
not in the initial bipotential cell fate decision of the hepatoblast
[17]. However, by P0 in wildtype littermates, patent bile ducts
were beginning to form, while none were evident in the Hes1-null
mice. Unfortunately, Hes1-null mice die at birth from severe
central nervous system defects [18], precluding the analysis of later
stages of ductal plate remodeling and bile duct morphogenesis in
these mice.
Our analysis of Jag1
dDSL/+ Notch2
del1/+ mice supports the model
that Notch signaling regulates ductal plate remodeling and bile
Table 1. Blood Chemistry Analysis of Notch2-cko Mice.
Genotype n Alkaline Phosphatase Alanine Aminotransferase Blood Urea Nitrogen Total Bilirubin
Notch2-cko 23 366634 135627 2460.7 0.7160.14
Controls 29 246695 2 692 2 60.8 0.4960.02
Serum from 4–5 week old Notch2-cko mice and their littermates were analyzed for the indicated parameters. Values shown are the mean (in International Units/
Liter)6standard error of the mean. All genotypes other than Notch2-cko were combined for controls.
doi:10.1371/journal.pone.0001851.t001
Figure 5. Notch signaling regulates bile duct morphogenesis
independently of HNF6 and HNF1b. A–D. HNF1b expression in
Notch2-cko mice at P7 and P0. E,F. HNF6 expression in Jag1
dDSL/+
Notch2
del1/+ mice at P0. The HNF1b and HNF6 proteins were expressed
similarly in the periportal region (arrowheads) of both control littermate
and mutant livers.
doi:10.1371/journal.pone.0001851.g005
Figure 4. Defects in bile duct formation in Notch2-cko mice
using either the Notch2
del2 or Notch2
del3 alleles. A,B. Hematoxylin
and eosin-stained sections at P7 of control littermate (CT) and Notch2-
cko mice using the Notch2
del2 allele. Bile ducts (arrow) are observed in
the periportal region of the control littermate (A), but not the Notch2-
cko mouse (B). C–F. DBA lectin staining. C,D. Control littermate and
Notch2-cko mice using the Notch2
del2 allele at P7. E,F. Control littermate
and Notch2-cko mice using the Notch2
del3 allele at P3. DBA-positive cells
form patent bile ducts (arrows) adjacent to the portal veins in control
mice (C,E). In Notch2-cko mice using either the Notch2
del2 (D) or
Notch2
del3 (F) allele, small numbers of DBA-positive cells (arrowheads)
are present adjacent to the portal veins, but these cells have not formed
patent ducts. G,H. Cytokeratin immunostaining of control littermate
and Notch2-cko mice (Notch2
del2 allele) at P7. The ductal plate of the
control liver (G) has remodeled into epithelial bile ducts (arrows), while
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suggests that the Jag1/Notch2-mediated signal responsible for bile
duct morphogenesis acts, at least in part, by modulating Hes1
expression. Our analysis of bile duct formation in Notch2-cko mice
is consistent with this model. While the Alb1-Cre transgene does not
delete early enough during embryogenesis to study the role of
Notch2 gene function during ductal plate formation [29], the
essentially identical biliary tract defects exhibited by the Jag1
dDSL/
+ Notch2
del1/+ and Notch2-cko mice at late embryonic and postnatal
stages strongly suggest that these defects arise by the same
mechanism in both mouse models. However, it remains possible
that Notch signaling may play some role in cholangiocyte
differentiation, since none of the three mouse models analyzed
(Hes1-null mice, Jag1
dDSL/+ Notch2
del1/+ mice, and Notch2-cko mice)
are likely to be entirely deficient in Notch signaling when the
cholangiocyte-hepatocyte cell fate decision is made.
In contrast to Notch2 deletion, deletion of the Jag1 gene in liver
hepatoblasts did not lead to defects in bile duct development [30],
suggesting that Jag1 expression in endothelial cells and/or vascular
smooth muscle cells was sufficient for signaling to Notch2-
expressing hepatoblasts during ductal plate remodeling and bile
duct morphogenesis. Interestingly, this study also demonstrated
that in mice that were compound heterozygotes for a Jag1 null
allele and the Jag1 conditional allele deleted in hepatoblasts, a
subset of animals exhibited bile duct proliferation [30]. Other
recent studies support a model in which cholangiocyte differen-
tiation is controlled by a gradient of Activin/TGFb signaling that
is controlled by the expression of Onecut-family transcription
factors, such as HNF6 and Onecut2 (OC2) [31,32]. Our results
suggest that Notch signaling regulates bile duct morphogenesis
independently of the Activin/TGFb/Onecut pathway.
In summary, we demonstrate here that similar defects in bile
duct formation were observed in both Jag1
dDSL/+ Notch2
del1/+ and
Notch2-cko mice. However, Jag1
dDSL/+ Notch2
del1/+ mice exhibit
defects in many organ systems other than the biliary tract, such as
the heart and the kidney [15]. We suggest that liver-specific
deletion of the Notch2 gene in Notch2-cko mice represents an
improved and more specific model than Jag1
dDSL/+ Notch2
del1/+










described previously [15,16,19,25]. Albumin-Cre (Alb1-Cre) mice
[23,24] were obtained from the Jackson Laboratory. To produce
Alb1-Cre/+; Notch2
flox/- mice (referred to as Notch2-cko, for Notch2
conditional knockout), Notch2
flox/flox mice were mated to mice
heterozygous for both the Alb1-Cre transgene and either the
Notch2
del2 or Notch2
del3 alleles. Animal maintenance and experi-
mental procedures were in accordance with the NIH Guidelines
for Animal Care and Use and the principles of the Helsinki
Declaration, and were approved by the Institutional Animal Care
and Use Committee of the Jackson Laboratory.
Immunohistochemistry and lectin binding
The antibodies and lectins used in these studies were rabbit
polyclonal anti-human cytokeratins (Dako, Cat. A0575); rabbit
polyclonal anti-HNF1b (Santa Cruz, Cat. sc-22840); rabbit
polyclonal anti-HNF6 (Santa Cruz, Cat. sc-13050); and biotiny-
lated Dolichos biflorus agglutinin (DBA) lectin (Vector Laboratories,
Cat. B-1035). Mutant sections were either Jag1
dDSL/+ Notch2
del1/+
or Notch2-cko. Other genotypes, with the exception of Jag1
dDSL/+,
were used as littermate controls. No differences were noted in the
phenotypes exhibited by the different control genotypes.
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